The case for homebrew AI in diagnostic pathology
The Journal of Pathology · 2025
DOI: 10.1002/path.6438 ↗At a glance
Journal article in The Journal of Pathology, 2025. Written by Julien Calderaro and 4 co-authors. Institution: Département de Pathologie, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France. Major MEDLINE topics: Artificial Intelligence, Image Interpretation, Computer-Assisted, Pathology, Clinical. Cited 13 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Artificial intelligence (AI) methods for digital pathology have tremendous potential to improve cancer diagnostics, biomarkers, and ultimately patient care. These AI methods, if marketed and sold, require authorisation or clearance as in vitro diagnostic (IVD) devices by regulatory bodies like the Food and Drug Administration (FDA) in the USA or Notified Bodies in the European Union (EU). Many AI tools for digital pathology are unlikely to be commercially viable and taken up by commercial entities ready to navigate these complex and costly processes. However, a longstanding quality framework already exists that allows for lab‐developed tests, colloquially known as ‘homebrew’ tests, that are locally validated and performed under the responsibility and oversight of the pathologist. Here we argue for advancing homebrew AI systems within this existing framework to enhance patients' access to supportive digital diagnostic tools. We outline how homebrew AI models are currently permitted under regulatory provisions in the USA and the European Union, how a new US FDA rule may effectively regulate them out of existence, and propose steps to facilitate the safe and effective integration of homebrew AI models in pathology practice. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Département de Pathologie, Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Créteil, France.
- MINT-HEP Mondor Integrative Hepatology, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, Créteil, France.
- AMMF-The Cholangiocarcinoma Charity, Chelmsford, UK.
- INSERM U1240, [Molecular Imaging & Theragnostic Strategies (IMOST)], University Clermont Auvergne, Clermont-Ferrand, France.
- Department of Pathology, Centre Jean PERRIN, Clermont-Ferrand, France.
- Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Dresden, Germany.
Cite
APA
Calderaro, J., Morement, H., Penault-Llorca, F., Gilbert, S., & Kather, J. N. (2025). The case for homebrew AI in diagnostic pathology. The Journal of Pathology. https://doi.org/10.1002/path.6438
Vancouver
Calderaro J, Morement H, Penault-Llorca F, Gilbert S, Kather JN. The case for homebrew AI in diagnostic pathology. The Journal of Pathology. 2025. doi:10.1002/path.6438
BibTeX
@article{Calderaro2025,
author = {Calderaro, Julien and Morement, Helen and Penault-Llorca, Frédérique and Gilbert, Stephen and Kather, Jakob Nikolas},
title = {The case for homebrew AI in diagnostic pathology},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6438}
}
EUVIMED